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Saudi Arabia, with the enrollment between November
2011 and October 2012. Of 500 patients referred for
elective CARDIAC surgery, 100 (20%) met criteria for
high risk of developing PPCs, of whom were enrolled
and followed up until discharge from hospital after
dividing him to two groups, our new preoperative chest
preparation strategy group (group A) and classic
routinely used group (group B).
Intervention: Patients were randomly assigned to
receive either preoperative strategy (n = 50) or usual care
B strategy (n = 50). Both groups received the postopera-
tive physical therapy.
Main outcome measures: Incidence of PPCs espe-
cially pneumonia, duration of postoperative intubation
and invasive ventilation, Intensive Care Unit (ICU) stay
and hospitalization incidence of requiring re-intubation
and impact of both strategies on postoperative patient
compliance to respiratory therapy.
Results: Both groups were comparable at baseline.
After CARDIAC surgery, PPCs were present in 10
(20%) of patients in the A group and 25 (50%) of patients
B group. Pneumonia occurred in 5 (10%) of patients in the
A group and in 7 (14%) of patients in the B (OR 95% CI).
Median days range 6–18 days in the B group. Finally,
postoperative patients compliance to respiratory therapy
was significantly improved.
Conclusion: Preoperative A strategy reduced the
incidence of PPCs an duration of postoperative hospital-
ization in patients at high risk of developing pulmonary
complication undergoing CARDIAC surgery. Also, post-
operative patient compliance to respirartory therapy
was significantly improved.
http://dx.doi:10.1016/j.jsha.2013.03.175
Current outcomes of the Glenn bidirectional cavo-
pulmonary connection for single ventricle
palliation
Waheed Raedi, Majid Al Fayyadh, Momdouh Al
Ahmadi, Bahaa Alsoufi
Objectives: The Glenn bidirectional cavopulmonary
connection (BCPC) is an established procedure in multi-
stage palliation of various single ventricle anomalies. We
aimed to report current outcomes following BCPC and to
examine risk factors affecting survival and progression to
next palliation stage.
Methods: 227 consecutive children with variable sin-
gle ventricle pathologies underwent BCPC from 2002 to
2007. Competing risks analyses were performed to model
events after BCPC (death and transition to Fontan) and
subsequently after Fontan (death and cardiac reopera-
tion); and to examine associated risk factors for poor
outcomes.
Results: There were 139 males (61%) with median age
of 7.6 months (interquartile range (IQR) 6.0–10.8) and med-
ian weight of 6.2 kg (IQR 5.2–7.4). Forty-three patients (19%)
had primary BCPC and 184 (81%) had prior palliation: aor-
topulmonary shunt (n = 83), Norwood (n = 55), pulmonary
artery band (n = 48), atrial septectomy (n = 25), pulmonary
artery reconstruction (n = 14), anomalous pulmonary
venous connection repair (n = 7), other (n = 8). Predomi-
nant ventricle was left morphology (n = 122, 54%), right
morphology (n = 95, 42%), two equally developed ventri-
cles (n = 10, 4%). Twenty-six patients (12%) had bilateral
SVC. Concomitant surgery included atrioventricular valve
repair (n = 18), pulmonary artery augmentation (n = 80),
percutaneous Fontan preparation (n = 34), other (n = 24).
Competing risks analysis showed that 5-years following
BCPC, approximately 17% have died, 76% have undergone
Fontan and 7% were alive awaiting or not qualifying for
Fontan. On multivariable analysis, risk factors for death
prior to Fontan were PVRI > 3 WU/M2 (HR 3.9, p = 0.001),
dominant right ventricle (HR 2.1, p = 0.03), prior palliation
other than aortopulmonary shunt (HR 0.4, p = 0.03). Com-
peting risks analysis showed that 3-years following 172
Fontan operations, approximately 10% have died, 6% have
undergone further cardiac surgery and 84% were alive and
free from reoperation. Overall, 8-year survival following
BCPC was only 74%.
Conclusions: Despite established selection criteria
and improved surgical technique and medical manage-
ment, there is a continuous failure and attrition risk fol-
lowing BCPC. Outcomes are influenced by underlying
cardiac anomaly; patients with dominant left ventricle
(i.e. tricuspid atresia, DILV) having the best survival
while those with dominant right ventricle (i.e. HLHS,
DORV with heterotaxy) having the worst survival.
Increased pulmonary vascular resistance remains a sig-
nificant factor affecting mortality.
http://dx.doi:10.1016/j.jsha.2013.03.176
Role of biomarkers to identify individuals with
silent cardiac disease to help improve primary
prevention
Yahia M. Elrakshy a, Akram M. Fayed b
aCardiology Department, Alexandria University Hospi-
tal, Egypt; bCritical Care Department, Faculty of Med-
icine, Alexandria, Egypt
Objectives: The aim of this study was to evaluate
power of identification of silent cardiac target organ dam-
age (TOD) in population receiving primary prevention
with the use of biomarkers.
Background: Primary prevention of cardiovascular
events could be improved by identifying patients with
silent cardiac TOD (i.e., myocardial ischemia, systolic
dysfunction, diastolic dysfunction, left ventricular hyper-
trophy or left atrial enlargement). Biomarkers used for
screening included high sensitive CRP [hs-CRP], high
sensitivity cardiac troponin T [hs-cTnT], or B-type natri-
uretic peptide [BNP].
Methods: The study included 271 asymptomatic
individuals already receiving primary prevention
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